col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


16 Results       Page 1

 [1] 
American Chemical Society: Molecular Pharmaceutics
  original article Date Title Authors   All Authors
1 [GO] 2025―Sep―17 Choline-Retinoic Acid Ionic Liquid [Cho][Ra] as Potential Adjuvant to Enhance Humoral, Cellular, and Mucosal Immune Responses of SARS-CoV-2 RBD Antigen Hongyu Zhu, Sen Yang, Jingyang Zhao, Liuyang Wang, Chenghao Gao, Yanan Sheng, et al. (+5)
2 [GO] 2025―Jul―24 Rapid Discovery of Potent Neutralizing Antibodies against SARS-CoV-2 through Directed Evolution of SARS-CoV-1 Antibodies Inji Jung, Dinesh Kumar Sriramulu, Jeong Hyeon Yoon, Jisun Lee, Tae Woo Kim, Dae-Hyuk Kweon, et al. (+2)
3 [GO] 2024―Jul―26 Enhanced Omicron Variant Neutralization by a Human Antibody Tailored to Wild-Type and Delta-Variant SARS-CoV-2 RBDs Jisun Lee, Bomi Kim, Hye-Min Woo, Jun-Won Kim, Inji Jung, Seong-Wook Park, et al. (+3)
4 [GO] 2024―Jun―26 Development of Broad-Spectrum Nanobodies for the Therapy and Diagnosis of SARS-CoV-2 and Its Multiple Variants Lei He, Qian Wu, Zhaoyong Zhang, Lingling Chen, Kuai Yu, Leibin Li, et al. (+10)
5 [GO] 2024―Jan―30 SARS-CoV-2 NSP2 as a Potential Delivery Vehicle for Proteins Ningze Zheng, Shurui Liu, Jianheng Chen, Yue Xu, Wenyin Cao, Jinyi Lin, et al. (+2)
6 [GO] 2023―Nov―09 Designing Cell Delivery Peptides and SARS-CoV-2-Targeting Small Interfering RNAs: A Comprehensive Bioinformatics Study with Generative Adversarial Network-Based Peptide Design and In Vitro Assays Ricardo D. González, Susana Simões, Lino Ferreira, Alexandra T. P. Carvalho
7 [GO] 2023―Sep―12 Trivalent mRNA Vaccine against SARS-CoV-2 and Variants with Effective Immunization Ji Wang, Yanhao Zhang, Chao Liu, Wenhui Zha, Shuo Dong, Yang Wang, et al. (+3)
8 [GO] 2023―Mar―23 Investigating Generation of Antibodies against the Lipid Nanoparticle Vector Following COVID-19 Vaccination with an mRNA Vaccine Rasmus Münter, Erik Sørensen, Rasmus B. Hasselbalch, Esben Christensen, Susanne D. Nielsen, Peter Garred, et al. (+5)
9 [GO] 2023―Jan―20 Safety, Biodistribution, and Dosimetry Study of Meplazumab, a Potential COVID-19 Therapeutic Drug, with 131I-Labeling and SPECT Imaging Jiajun Ye, Weidong Yang, Zhaojuan Xie, Yuhao Yan, Guoquan Li, Guiyu Li, et al. (+5)
10 [GO] 2022―Nov―30 Telmisartan Nanosuspension for Inhaled Therapy of COVID-19 Lung Disease and Other Respiratory Infections Daiqin Chen, Xin Yun, Daiheon Lee, Joseph R. DiCostanzo, Oreola Donini, Cecilia M. Shikuma, et al. (+4)
11 [GO] 2022―Sep―06 A Positron Emission Tomography Tracer Targeting the S2 Subunit of SARS-CoV-2 in Extrapulmonary Infections Jianzhong Xian, Hongbin Huang, Guolong Huang, Renwei Zhou, Min Yang, Yifan Qiu, et al. (+5)
12 [GO] 2021―Dec―06 Voices in Molecular Pharmaceutics: Meet Dr. Venecia Wilson, a Scientist Helping to Maintain a Robust Supply Chain for the Manufacture of COVID-19 Vaccines Venecia R. Wilson
13 [GO] 2021―May―13 The Possible Role of Sex As an Important Factor in Development and Administration of Lipid Nanomedicine-Based COVID-19 Vaccine Elisabetta Vulpis, Francesca Giulimondi, Luca Digiacomo, Alessandra Zingoni, Reihaneh Safavi-Sohi, Shahriar Sharifi, et al. (+2)
14 [GO] 2021―May―04 siRNA Therapeutics for the Therapy of COVID-19 and Other Coronaviruses Muhammad Imran Sajid, Muhammad Moazzam, Yeseom Cho, Shun Kato, Ava Xu, J. J. Way, et al. (+2)
15 [GO] 2021―Jan―19 COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies Vrishali S. Salian, Jessica A. Wright, Peter T. Vedell, Sanjana Nair, Chenxu Li, Mahathi Kandimalla, et al. (+4)
16 [GO] 2020―May―07 Emerging Biomolecular Testing to Assess Risk of Mortality from COVID-19 Infection Morteza Mahmoudi
 [1] 

16 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.006 sec